MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 105 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $20,000 | -57.4% | 16,452 | +8.9% | 0.00% | -50.0% |
| Q1 2017 | $47,000 | -24.2% | 15,112 | +0.1% | 0.00% | -33.3% |
| Q4 2016 | $62,000 | -25.3% | 15,104 | +15.2% | 0.00% | -40.0% |
| Q3 2016 | $83,000 | +23.9% | 13,109 | +0.4% | 0.01% | +25.0% |
| Q2 2016 | $67,000 | -34.3% | 13,055 | +7.0% | 0.00% | -60.0% |
| Q1 2016 | $102,000 | +17.2% | 12,202 | +10.7% | 0.01% | -9.1% |
| Q4 2015 | $87,000 | -11.2% | 11,024 | -4.7% | 0.01% | +10.0% |
| Q3 2015 | $98,000 | -30.5% | 11,562 | +1.6% | 0.01% | -28.6% |
| Q2 2015 | $141,000 | +161.1% | 11,382 | +13.4% | 0.01% | +55.6% |
| Q4 2013 | $54,000 | – | 10,034 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |